# Ilika Plc Stereax Production Milestone Signals a Bright Future – Cavendish

- Link: https://www.directorstalkinterviews.com/ilika-plc-stereax-production-milestone-signals-a-bright-future-cavendish/4121183292
- Published: 2025-01-11T07:30:00+00:00
- Author: Anthony Fox

**[Ilika plc](https://www.directorstalkinterviews.com/company/ilika-plc/ika.l)**(
[LON:IKA](https://www.directorstalkinterviews.com/company/ilika-plc/ika.l)) has 
announced a significant advancement in its development of solid-state battery (SSB)
technology. Its Stereax® production equipment, now fully operational at Cirtec Medical’s
facility in Lowell, Massachusetts, has passed rigorous User Acceptance Tests (UATs).
This achievement signifies that Ilika and Cirtec are confident the manufacturing
infrastructure meets all requirements to commence production.

The production of Stereax batteries has already started, initially focused on internal
process qualification, with plans to ship to the first 21 customers in the near 
future. This milestone marks an important step towards commercial sales, a transformative
event anticipated to occur this year.

John-Marc Bunce, Director of Research at Cavendish, highlighted the significance
of this development:
_“Getting to the SOP with a licensee is a major milestone for
this SSB technology. The next step of a validated product sale through Cirtec is
not far away now, and this will be viewed as a major and transformative commercial
milestone for Ilika.”_

The initial production cycle will focus on ensuring the manufacturing process produces
products that meet specifications with sufficient yields. The cathode deposition
process remains at Ilika’s UK facilities, with other specialist steps outsourced,
resulting in a production timeline of approximately four months. This is in line
with Ilika’s objective of achieving its first third-party sales through Cirtec in
the second half of this calendar year.

Ilika plc stands poised to generate revenue from wafer processing before achieving
full commercial sales. This revenue stream will commence in the coming months as
the company progresses towards profit sharing from product sales.

Cavendish remains optimistic about Ilika’s competitive positioning. The Stereax 
technology has overcome numerous technical hurdles, placing Ilika at the forefront
of the global race to deliver reliable SSB solutions. Despite its discounted valuation
compared to competitors, Ilika offers an attractive entry point for investors, with
a target price of 83p and an upside potential of 291%.

**Final Thoughts**
Ilika’s progress in Stereax production represents a pivotal moment,
reinforcing its leadership in solid-state battery technology. With commercial milestones
on the horizon, the company is well-placed to capture significant market opportunities,
demonstrating its resilience and innovation in the clean energy sector.

Share on:
